Causes of Death Following Gastric Cancer Diagnosis: A Population-Based Analysis.
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
23 May 2023
23 May 2023
Historique:
medline:
24
5
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
epublish
Résumé
BACKGROUND Causes of death (CODs) in patients with gastric cancer (GC) need to be studied. We examined the cancer-specific and non-cancer deaths among patients diagnosed with GC from 1975 to 2019. MATERIAL AND METHODS We obtained medical records from the Surveillance, Epidemiology, and End Results (SEER) database. We used SEER*Stat software to calculate standardized mortality ratios (SMRs) for specific CODs and performed a competing risk analysis to evaluate the cumulative mortality of specific CODs. RESULTS The final study cohort included 42 813 patients with GC, with a mean age at diagnosis of 67.7 years. As the end of 2021, a total of 36 924 (86.2%) patients died. Of these deaths, 24 625 (66.7%) were from GC, 6513 (17.6%) were from other types of cancers, and 5786 (15.7%) were from non-cancer causes. The most prevalent non-cancer CODs were heart diseases (2104; 5.7%), cerebrovascular diseases (501; 1.4%), and pneumonia/influenza (335; 0.9%). Among patients who survived over 5 years, non-cancer causes surpassed GC as the main CODs. Patients with GC had a higher risk of dying from many non-cancer causes than expected in the general population, particularly from suicide (SMR, 3.03; 95% CI, 2.35-3.85) and septicemia (SMR, 2.93; 95% CI, 2.51-3.4). The competing risk analysis showed that the cumulative mortality of GC gradually declined with a more recent diagnosis. CONCLUSIONS Although GC was the leading COD among patients with GC, non-cancer CODs accounted for a substantial number of deaths. These findings provide useful guidance on potential death risks among patients with GC.
Identifiants
pubmed: 37218118
pii: 939848
doi: 10.12659/MSM.939848
pmc: PMC10224633
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e939848Références
Clin Epidemiol. 2021 Jul 02;13:515-525
pubmed: 34239328
Acta Cardiol Sin. 2021 Sep;37(5):457-463
pubmed: 34584378
J Surg Oncol. 2019 Dec;120(8):1371-1378
pubmed: 31696512
Heart Fail Clin. 2022 Jul;18(3):489-501
pubmed: 35718421
Helicobacter. 2019 Sep;24 Suppl 1:e12635
pubmed: 31486242
Cancer Med. 2021 Apr;10(8):2740-2751
pubmed: 33314795
Cancer Chemother Pharmacol. 2019 Sep;84(3):599-607
pubmed: 31203389
Cancer. 2020 Apr 1;126(7):1559-1567
pubmed: 31840240
Ann Thorac Med. 2018 Apr-Jun;13(2):76-81
pubmed: 29675057
Circulation. 2019 Feb 26;139(9):e44-e54
pubmed: 30674212
Bone Marrow Transplant. 2010 Sep;45(9):1388-95
pubmed: 20062101
N Engl J Med. 2020 Jun 18;382(25):2419-2430
pubmed: 32469182
Cancers (Basel). 2020 Jul 27;12(8):
pubmed: 32726933
Cardiol Clin. 2019 Nov;37(4):407-418
pubmed: 31587782
Circulation. 2021 Jul 20;144(3):e41-e55
pubmed: 34134525
BMC Pulm Med. 2022 Jul 4;22(1):262
pubmed: 35787685
Eur J Clin Nutr. 2022 Oct;76(10):1449-1456
pubmed: 35354923
Eur J Cancer Prev. 2022 Jul 1;31(4):326-332
pubmed: 34456259
BJU Int. 2016 Apr;117(4):551-2
pubmed: 26190064
Eur Heart J. 2022 Jan 03;:
pubmed: 34974609
Gan To Kagaku Ryoho. 2019 Dec;46(13):2243-2245
pubmed: 32156892
Eur J Surg Oncol. 2016 Jan;42(1):132-9
pubmed: 26385054
Circulation. 2021 Feb 23;143(8):837-851
pubmed: 33617315
J Gastrointest Oncol. 2017 Oct;8(5):897-901
pubmed: 29184695
Cancer Epidemiol. 2011 Apr;35(2):126-31
pubmed: 20952269
Surg Today. 2016 May;46(5):552-6
pubmed: 26077287
Ann Palliat Med. 2022 Sep;11(9):2813-2818
pubmed: 35948471
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
BMC Cancer. 2018 Jul 27;18(1):765
pubmed: 30053850
BMJ. 2016 Sep 01;354:i4351
pubmed: 27586237
Oncologist. 2021 Sep;26(9):733-739
pubmed: 34101294
Circulation. 2022 Apr 12;145(15):e811-e838
pubmed: 35249373
Int Angiol. 2017 Feb;36(1):1-20
pubmed: 27606807
BMC Surg. 2022 Jun 7;22(1):220
pubmed: 35672847
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):277-287
pubmed: 28404157
Curr Oncol Rep. 2022 May;24(5):543-553
pubmed: 35192118
Prz Gastroenterol. 2019;14(1):26-38
pubmed: 30944675
Curr Med Res Opin. 2017 Jul;33(7):1343-1348
pubmed: 28426338
Circulation. 2017 Mar 7;135(10):951-963
pubmed: 28082386
JAMA Netw Open. 2021 Aug 2;4(8):e2119568
pubmed: 34351403
Curr Oncol Rep. 2022 Nov;24(11):1579-1592
pubmed: 35796941
Cancer Treat Rev. 2017 Sep;59:123-131
pubmed: 28818671
Ann Surg Oncol. 2013 May;20(5):1575-83
pubmed: 23076557
Cancer Sci. 2020 Jul;111(7):2451-2459
pubmed: 32359209